CarthroniX Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.1M

  • Investors
  • 2

CarthroniX General Information

Description

Operator of a biopharmaceutical company designed to help in stem cell activation and tissue regeneration. The company utilizes molecular technology to advance therapies for degenerative and aging-related diseases, including arthritis, that help to preserve, repair, and regenerate cartilage in joints, suppress inflammation, heal wounds, regenerate skin, and prevent tissue fibrosis, enabling patients to enhance their physical activity and health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 43364 10th Street West
  • Suite A
  • Lancaster, CA 93534
  • United States
+1 (949)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 43364 10th Street West
  • Suite A
  • Lancaster, CA 93534
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CarthroniX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2023 $5.1M Completed Clinical Trials - Phase 1
2. Later Stage VC 22-Apr-2022 Completed Clinical Trials - Phase 1
1. Seed Round 12-Dec-2019 $2.3M $2.3M Completed Clinical Trials - Phase 1
To view CarthroniX’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CarthroniX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company designed to help in stem cell activation and tissue regeneration. The company ut
Drug Discovery
Lancaster, CA
3 As of 2025

Foster City, CA

Burnaby, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CarthroniX Competitors (18)

One of CarthroniX’s 18 competitors is Orthotrophix, a Formerly VC-backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orthotrophix Formerly VC-backed Foster City, CA
Qu Biologics Private Equity-Backed Burnaby, Canada
Ampio Pharmaceuticals Corporation Englewood, CO
Amplicore Venture Capital-Backed Mason, OH
Xalud Therapeutics Venture Capital-Backed New York, NY
You’re viewing 5 of 18 competitors. Get the full list »

CarthroniX Patents

CarthroniX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4746877-A1 Compositions and methods for modulating gp130 activity Pending 20-Jul-2023
WO-2025019851-A1 Compositions and methods for modulating gp130 activity Inactive 20-Jul-2023
EP-4511378-A1 Small molecule modulators of gp130 signaling pathways Pending 20-Apr-2022
EP-4511378-A4 Small molecule modulators of gp130 signaling pathways Pending 20-Apr-2022
US-20250333423-A1 Small molecule modulators of gp130 signaling pathways Pending 20-Apr-2022 C07D513/04
To view CarthroniX’s complete patent history, request access »

CarthroniX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CarthroniX Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Department of War Government
Pacira BioSciences Corporation Minority
To view CarthroniX’s complete investors history, request access »

CarthroniX FAQs

  • When was CarthroniX founded?

    CarthroniX was founded in 2015.

  • Where is CarthroniX headquartered?

    CarthroniX is headquartered in Lancaster, CA.

  • What is the size of CarthroniX?

    CarthroniX has 3 total employees.

  • What industry is CarthroniX in?

    CarthroniX’s primary industry is Drug Discovery.

  • Is CarthroniX a private or public company?

    CarthroniX is a Private company.

  • What is CarthroniX’s current revenue?

    The current revenue for CarthroniX is .

  • How much funding has CarthroniX raised over time?

    CarthroniX has raised $4.55M.

  • Who are CarthroniX’s investors?

    United States Department of War and Pacira BioSciences have invested in CarthroniX.

  • Who are CarthroniX’s competitors?

    Orthotrophix, Qu Biologics, Ampio Pharmaceuticals, Amplicore, and Xalud Therapeutics are some of the 18 competitors of CarthroniX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process